The Thrive-IVF Research Study is currently evaluating the efficacy, safety and tolerability of NT100, an investigational medicine in women who have had repeated in vitro fertilization (IVF) failures despite having good-quality embryos. NT100 is being evaluated to determine if it improves your chances of getting pregnant after IVF.

The research study is currently enrolling participants at approximately 20 sites across the United States.

Click About this Study to learn more.

Click here to see if you may qualify.







© CAHG, Inc. All rights reserved.